Cyclo Therapeutics Total Revenue

Cyclo Therapeutics (CYTH) currently reports a total revenue of $870K as of September 2024. That compares with $950K in the prior-year period — down 8.5% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Cyclo Therapeutics's total revenue history and peer comparisons.

Cyclo Therapeutics's total revenue decreased from $950K to $870K — a 8.5% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cyclo Therapeutics's total revenue of $870K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cyclo Therapeutics reported $870K in total revenue as of September 2024. That compares with $950K in the prior-year period — down 8.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $870K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Cyclo Therapeutics, and consider following CYTH for alerts when major investors trade the stock.